THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Premarket roundup: Baxter, Bristol-Myers Squibb

Email|Print|Single Page| Text size +
May 6, 2008

Among the Premarket stories for Tuesday, May 6, from AP Financial News:

NEW YORK (AP) -- Despite a first quarter in which Baxter International Inc. had to recall its blood thinner heparin amid a Food and Drug Administration investigation into contamination of the product, analysts say the company is poised for growth.

NEW YORK (AP) -- Bristol-Myers Squibb Co. will hold its annual stockholder meeting Tuesday and Wall Street may be looking for further updates on the company's ongoing restructuring plan.

WASHINGTON (AP) -- Medical experts will consider Tuesday whether use of a painkiller made by Cephalon Inc. should be expanded, despite government concerns about increased risks for abuse.

NEW YORK (AP) -- Analysts expect shares of McKesson Corp. to rise Tuesday after the prescription drug distributor reported a strong fiscal fourth quarter and forecast fiscal 2009 profit mostly above expectations.

NEW YORK (AP) -- A Piper Jaffray analyst says Omniture Inc.'s marketing strategy is working and sales are strong, and he upgraded the analytic software company's stock to "Buy" from "Neutral."

more stories like this

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.